Author:
Blauvelt Andrew,Papp Kim A.,Lebwohl Mark G.,Green Lawrence J.,Hsu Sylvia,Bhatt Varsha,Rastogi Shipra,Pillai Radhakrishnan,Israel Robert
Reference5 articles.
1. A prospective phase III, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis;Papp;Br J Dermatol,2016
2. Phase 3 studies comparing brodalumab with ustekinumab in psoriasis;Lebwohl;N Engl J Med,2015
3. Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials;Griffiths;Lancet,2015
4. Secukinumab in plaque psoriasis: results of two phase 3 trials;Langley;N Engl J Med,2014
5. Leonardi C, Langley R, Blauvelt A, et al. Rapid onset of efficacy in patients with psoriasis treated with ixekizumab: a pooled analysis of data from two randomized clinical trials (UNCOVER-2 and UNCOVER-3). Poster presented at Am Acad Dermatol Annual Meeting, March 2016, Washington, DC.
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献